Asset Details
Do you wish to reserve the book?
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
Do you wish to request the book?
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
2017
Overview
Atypical antipsychotic drugs (APDs) have been hypothesized to show reduced extrapyramidal side effects (EPS) due to their rapid dissociation from the dopamine D
2
receptor. However, support for this hypothesis is limited to a relatively small number of observations made across several decades and under different experimental conditions. Here we show that association rates, but not dissociation rates, correlate with EPS. We measured the kinetic binding properties of a series of typical and atypical APDs in a novel time-resolved fluorescence resonance energy transfer assay, and correlated these properties with their EPS and prolactin-elevating liabilities at therapeutic doses. EPS are robustly predicted by a rebinding model that considers the microenvironment of postsynaptic D
2
receptors and integrates association and dissociation rates to calculate the net rate of reversal of receptor blockade. Thus, optimizing binding kinetics at the D
2
receptor may result in APDs with improved therapeutic profile.
Atypical antipsychotics show reduced extrapyramidal side effects compared to first generation drugs. Here the authors use time-resolved FRET to measure binding kinetics, and show that side effects correlate with drug association rates to the D
2
receptor, while dissociation rates correlate with prolactin elevation.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
